Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Assesses the Role of Genetics & the Gut in Reactive Arthritis

Mary Beth Nierengarten  |  Issue: December 2018  |  December 18, 2018

Study Highlights

As mentioned above, the study looked at two main issues to understand the role of gut microbiota in the pathogenesis of reactive arthritis. The first issue was to characterize the types of bacteria present in the gut of patients who develop reactive arthritis/postinfectious spondyloarthritis compared with controls who were exposed to the same types of infections but did not develop disease. The second issue was to characterize the relationship of host genes to microbiota.

Dr. Manasson

Dr. Manasson

To do this, Dr. Manasson and colleagues focused on 64 adult subjects who all had a previous GI or GU infection. Of these, 32 subjects subsequently developed reactive arthritis/postinfectious spondyloarthritis and 32 did not. As mentioned previously, all participants were from Guatemala, a geographical region where HLA-B27 prevalence is low.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

All participants were between the ages of 18 and 55 years old and had experienced a GI, GU or sexually transmitted infection three to six months prior to study enrollment. Patients were excluded from the study if they were diagnosed with inflammatory bowel disease, psoriasis, other inflammatory arthritis or autoimmune disease, or active cancer.

Each participant underwent a clinical examination that included a history and physical examination, as well as ultrasound. Data collected included HLA typing and stool for microbiota analysis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study found that gut microbial richness and diversity were similar between both groups of patients, but that participants with reactive arthritis had significantly greater abundance of enteropathogens than controls. Specifically, the study found a significantly higher abundance of bacteria from the genus Erwinia, which is commonly linked to more than 97% of the gut bacteria, associated with reactive arthritis. These bacteria include Salmonella, Shigella and Yersinia. The study also found a higher abundance of the pathogen Pseudomonas in the participants who developed reactive arthritis than in controls.

Dr. Steere

Dr. Steere

In addition, the study found several gut commensals were decreased in the patients with reactive arthritis compared with controls. Specifically, control subjects were enriched in the Lachnospiraceae taxa, including Blautia, Coprococcus, Roseburia and Collinsella.

“Our study showed that the abundance of enteropathogens was increased and the abundance of commensal organisms was decreased in subjects who developed reactive arthritis/postinfectious spondyloarthritis compared to those who did not,” says Dr. Manasson, “which may suggest a susceptibility to disease development.”

Overall, Dr. Manasson says the study showed host genes were associated with particular microbial signatures and that differences in microbiota composition were found between patients who developed reactive arthritis and controls. “We believe that genes may predispose individuals to certain gut microbial signatures, which, in the right setting, may make individuals more or less susceptible to disease after GU or GI infections,” she says.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:Genesgut microbiotaReactive arthritis

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences